(Q70247959)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6340081%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: prognostic factors and response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6340081%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: Prognostic factors and response (English)

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

2 October 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

2 October 2023

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

2 October 2023

author name string

W. D. DeWys

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340081

2 October 2023

C. B. Begg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340081

2 October 2023

H. Brodovsky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340081

2 October 2023

R. Creech

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340081

2 October 2023

J. Khandekar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340081

2 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6340081

2 October 2023

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6340081%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

9 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.2990040102

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

https://onlinelibrary.wiley.com/doi/full/10.1002/pros.2990040102

2 October 2023

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

2 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6340081%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6340081%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6340081%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

1-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6340081%20AND%20SRC:MED&resulttype=core&format=json

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate

9 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

2 October 2023

Cancer Treatment Reports

3

61

317

Johnson

1977

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

2 October 2023

Prostatic carcinoma

4

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

Cancer chemotherapy reports

2 October 2023

5

4

31

Zelen

1973

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

The distribution of active bone marrow in the adult

2 October 2023

6

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

2 October 2023

9

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

2 October 2023

10

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

An exponential model relating censored survival data and concomitant information for prostatic cancer patients

2 October 2023

11

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

2 October 2023

12

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

2 October 2023

Cancer Treatment Reports

13

60

115

Eagan

1976

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

Combination chemotherapy with adriamycin and cis-diamminedichloroplatinum in patients with neoplastic diseases

2 October 2023

14

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate

2 October 2023

15

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.

2 October 2023

16

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

An analysis of the effects of changes from the assigned treatment in a clinical trial of treatment for prostatic cancer

2 October 2023

18

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

Treatment of Metastatic Endocrine-Unresponsive Carcinoma of the Prostate Gland With Multiagent Chemotherapy: indicators of Response to Therapy2

2 October 2023

19

1 reference

https://api.crossref.org/works/10.1002/PROS.2990040102

2 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6340081%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference